CorMedix (CRMD) Other Non-Current Assets (2010 - 2025)

CorMedix's (CRMD) quarterly Other Non-Current Assets came in at $642066.0 in Q2 2025, up 514.85% year-on-year from $104426.0 in Q2 2024, and little changed quarter-over-quarter from $642066.0 in Q1 2025.

CorMedix (CRMD) Other Non-Current Assets (2010 - 2025) Analysis & Trends

CorMedix has disclosed Other Non-Current Assets across 15 years of filings, most recently posting $642066.0 for Q2 2025.

  • Other Non-Current Assets for Q2 2025 came in at $642066.0, up 514.85% year-over-year; the trailing twelve-month figure through Jun 2025 was $642066.0 (up 514.85% YoY), and the FY2024 annual result was $105368.0, up 36.84% from the prior year.
  • Other Non-Current Assets came in at $642066.0 for Q2 2025 at CorMedix, roughly flat from $642066.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $642066.0 in Q1 2025 to a low of $77000.0 in Q4 2023.
  • The 5-year median for Other Non-Current Assets is $103251.0 (2023), against an average of $164763.2.
  • Across the five-year window, Other Non-Current Assets plunged 79.57% in 2021 and soared 518.33% in 2025, its largest moves.
  • CorMedix's Other Non-Current Assets stood at $102305.0 in 2021, then climbed by 21.21% to $124000.0 in 2022, then plunged by 37.9% to $77000.0 in 2023, then jumped by 36.84% to $105368.0 in 2024, then soared by 509.36% to $642066.0 in 2025.
  • The last three Other Non-Current Assets figures came in at $642066.0 (Q2 2025), $642066.0 (Q1 2025), and $105368.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 60,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.71 Bn 91.71 Bn - -
10 CorMedix 631,378.03 -154.57 Mn 107.31 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 642,066.00
Mar 31, 2025 642,066.00
Dec 31, 2024 105,368.00
Sep 30, 2024 105,084.00
Jun 30, 2024 104,426.00
Mar 31, 2024 103,838.00
Dec 31, 2023 77,000.00
Sep 30, 2023 102,664.00
Jun 30, 2023 102,370.00
Mar 31, 2023 102,345.00
Dec 31, 2022 124,000.00
Sep 30, 2022 114,000.00
Jun 30, 2022 102,308.00
Mar 31, 2022 129,000.00
Dec 31, 2021 102,305.00
Sep 30, 2021 102,302.00
Jun 30, 2021 102,300.00
Mar 31, 2021 102,295.00
Dec 31, 2020 191,000.00
Sep 30, 2020 182,892.00